Possible modulation of concurrent Parkinson’s disease in the management of metastatic GIST: a review of two cases

Watson-Fargie, T., Grosset, D.G. , White, J. and Cowie, F. (2018) Possible modulation of concurrent Parkinson’s disease in the management of metastatic GIST: a review of two cases. Journal of the Royal College of Physicians of Edinburgh, 48(3), pp. 242-245. (doi: 10.4997/JRCPE.2018.309) (PMID:30191913)

[img]
Preview
Text
191371.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

177kB

Abstract

Imatinib, a tyrosine kinase inhibitor, is the mainstay of treatment for resected high-risk (adjuvant and metastatic) gastrointestinal stromal tumour (GIST) – a rare form of sarcoma. There has been recent research into the neuroprotective role and modulation of dopaminergic neurones by imatinib through the abl pathway in Parkinson’s disease (PD). We describe two patients from a single cancer centre with concurrent diagnoses of PD and metastatic GIST receiving imatinib and standard PD management. The cases highlight a potential reduction in PD progression using Unified Parkinson’s Disease Rating Scale. Further research into repurposing of imatinib for PD may provide additional management options for this neurodegenerative illness.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Grosset, Dr Donald and White, Dr Jeffery and Watson-Fargie, Dr Taylor
Authors: Watson-Fargie, T., Grosset, D.G., White, J., and Cowie, F.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Journal of the Royal College of Physicians of Edinburgh
Publisher:Royal College of Physicians of Edinburgh
ISSN:1478-2715
ISSN (Online):2042-8189
Copyright Holders:Copyright © 2018 The Authors
First Published:First published in Journal of the Royal College of Physicians of Edinburgh 48(3):242-245
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record